Browsing Tag
gumokimab
3 posts
Akeso’s gumokimab enters NMPA review for ankylosing spondylitis after positive Phase III trial
Akeso files gumokimab for NMPA review in ankylosing spondylitis. Find out how this move expands its autoimmune pipeline beyond oncology.
Akeso advances cancer immunotherapy as Ivonescimab reaches Phase III milestone in lung cancer treatment
Akeso, Inc. (9926.HK) has completed patient enrollment for its pivotal Phase III trial (HARMONi-6), marking a significant step…
Akeso’s Gumokimab poised to redefine Psoriasis treatment
Akeso, Inc., a leading biopharmaceutical innovator based in Hong Kong, is making significant strides in the treatment of…